Genomics | CHOP Research Institute


Dr. Gandal investigates the genetic contributions to typical human brain development and neurodevelopmental and psychiatric disorders. His multidisciplinary research program integrates genetics with functional genomic profiling in the human brain, along with bioinformatics and computational biology.

gandalm [at]
Published on
Jan 29, 2024
With funding from the National Cancer Institute’s Childhood Cancer Data Initiative, CHOP researchers are identifying new immunotherapy targets.
Published on
Dec 28, 2023
These six stories received the highest number of engagements on CHOP Research social media channels in 2023.

For this study, we are studying the relationship between variations in the genes of the immune system called HLA and how they relate to the risk of developing nephrotic syndrome, response to treatment of nephrotic syndrome and risk of recurrence of nephrotic syndrome following kidney transplantation.

Published on
Jun 5, 2023
Dimitrios Monos, PhD, received the 2022 Rose Payne Award from ASHI for his contributions to the field of Immunogenetics research.

The Thom Lab, an integrated genomics and cell biology lab, aims to define novel factors that regulate blood cell development and function in order to augment in vitro blood cell production.

Published on
Feb 15, 2023
Ingo Helbig, MD, discusses the Arcus Omics Data launch at CHOP in a Q&A.

The Campbell Lab strives to develop approaches to genetic diagnosis so that every child with a genetic disease is diagnosed as quickly and accurately as possible. By harnessing the CHOP electronic health record, the lab uses state-of-the art techniques to define and diagnose genetic diseases.

Dr. Campbell is interested in approaches to improve diagnosis of children with rare genetic diseases. He also focuses on better understanding of the full spectrum of symptoms associated with genetic diseases as well as discovering new diseases.

campbellim [at]

The Center for Spatial and Functional Genomics is focused on uncovering the correct functional context of variants identified by genome-wide association studies in order to translate these discoveries into meaningful benefits for pediatric care.